Company: SNWV
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050280
Chunk: 87

Company: SANUWAVE Health, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 8
Chunk 87
---
 by the Company for the three and nine months ended September 30, 2025. Total unrecognized compensation cost related to equity awards as of September 30, 2025 was $10.1 million and is expected to be recognized over a weighted average period of 2.36 years. All stock compensation expense from the Stock Incentive Plan was recognized prior to 2024. The first grants from the 2024 Plan were issued in the three months ended December 31, 2024, thus there is no expense for the three and nine months ended September 30, 2024. The Company recognizes compensation expense on a straight-line basis over the requisite service period, net of actual forfeitures.Three Months Ended September 30,Nine Months Ended September 30,(in thousands)20252025Cost of revenues$14 $32 General and administrative1,182 2,889 Selling and marketing192557Research and development935Total expense$1,397 $3,513 The following table presents a summary of stock options award activity during the nine months ended September 30, 2025:

19

Number of Options (in thousands)Weighted Average Exercise PriceWeighted Average Remaining Contractual Term (Years)Aggregate Intrinsic Value (in thousands)Outstanding, December 31, 20241,137 $15.97 9.5$9,305 Granted426 29.55 6.91,432 Exercised(25)14.68 0.0471 Forfeited(187)19.66 0.0- Outstanding, September 30, 20251,351 $19.03 8.6$24,099 Exercisable, September 30, 2025402 $25.15 7.9$7,454 Valuation Information for Stock-Based CompensationThe fair value of each stock option award during the three and nine months ended September 30, 2025 was based on the closing price of the Company's common stock on the date of the grant. Expected volatility was based on 100% of the historical realized volatilities of peer companies. The risk-free interest rate was based on the implied yield for U.S. Treasury zero-coupon issue with the remaining term equal to the expected term. The expected holding period was calculated using the simplified method. No dividend was assumed as the Company does not pay regular dividends on its common stock and does not anticipate